SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-063223
Filing Date
2010-07-01
Accepted
2010-07-01 17:29:29
Documents
11
Period of Report
2010-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c03090e8vk.htm 8-K 40233
2 EXHIBIT 2.1 c03090exv2w1.htm EX-2.1 363256
3 EXHIBIT 10.1 c03090exv10w1.htm EX-10.1 294942
4 EXHIBIT 10.2 c03090exv10w2.htm EX-10.2 74364
5 EXHIBIT 10.3 c03090exv10w3.htm EX-10.3 41513
6 EXHIBIT 10.4 c03090exv10w4.htm EX-10.4 38212
7 GRAPHIC c03090c0309001.gif GRAPHIC 16162
8 GRAPHIC c03090c0309002.gif GRAPHIC 18053
9 GRAPHIC c03090c0309003.gif GRAPHIC 7061
10 GRAPHIC c03090c0309004.gif GRAPHIC 12935
11 GRAPHIC c03090c0309005.gif GRAPHIC 7925
  Complete submission text file 0000950123-10-063223.txt   940376
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16132 | Film No.: 10931812
SIC: 2834 Pharmaceutical Preparations